US Patent 8858621 Methods of implanting a prosthetic heart valve

Patent 8858621 was granted and assigned to Edwards Lifesciences on October, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Edwards Lifesciences

Current Assignee

Edwards Lifesciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88586210

Patent Inventor Names

Louis A. Campbell0

Travis Zenyo Oba0

Date of Patent

October 14, 2014

Patent Application Number

139185090

Date Filed

June 14, 2013

Patent Citations Received

‌

US Patent 11840559 Glucagon-receptor selective polypeptides and methods of use thereof

‌

US Patent 11654183 Methods comprising continuous administration of exenatide and co-administration of a drug

Patent Primary Examiner

‌

Dianne Dornbusch

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8858621 Methods of implanting a prosthetic heart valve

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API